JIN-A02
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for JIN-A02, covering 2025-05-16 to 2025-05-16. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLC [Phase 1, Phase 2]